100 related articles for article (PubMed ID: 12699879)
1. Concentrations of soluble Fas in maternal serum and amniotic fluid during uncomplicated pregnancies.
Malamitsi-Puchner A; Sarandakou A; Papagianni V; Protonotariou E; Tziotis J; Botsis D
J Soc Gynecol Investig; 2003 Apr; 10(3):158-60. PubMed ID: 12699879
[TBL] [Abstract][Full Text] [Related]
2. Amniotic fluid soluble fas levels in intra-amniotic infection.
Hsu CD; Hong SF; Harirah H; Bahado-Singh R; Lu Lc
Obstet Gynecol; 2000 May; 95(5):667-70. PubMed ID: 10775726
[TBL] [Abstract][Full Text] [Related]
3. Soluble Fas and Fas-ligand levels in mid-trimester amniotic fluid and their associations with severe small for gestational age fetuses: a prospective observational study.
Vrachnis N; Dalainas I; Papoutsis D; Samoli E; Rizos D; Iliodromiti Z; Siristatidis C; Tsikouras P; Creatsas G; Botsis D
J Reprod Immunol; 2013 Jun; 98(1-2):39-44. PubMed ID: 23582102
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of soluble concentration Fas and Fas ligand in maternal and cord blood 3rd trimester of pregnancy.
Karowicz-Bilińska A; Kowalska-Koprek U; Estemberg D; Sikora-Szubert A
Ginekol Pol; 2018; 89(3):142-146. PubMed ID: 29664549
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of soluble Fas during normal pregnancy.
Hoshimoto K; Hayashi M; Ohkura T
Gynecol Obstet Invest; 2001; 51(2):96-8. PubMed ID: 11223701
[TBL] [Abstract][Full Text] [Related]
6. Soluble Fas antigen and soluble Fas ligand in early neonatal life.
Sarandakou A; Protonotariou E; Rizos D; Soubassi L; Malamitsi-Puchner A
Early Hum Dev; 2003 Dec; 75(1-2):1-7. PubMed ID: 14652155
[TBL] [Abstract][Full Text] [Related]
7. Tissue polypeptide specific antigen and soluble Fas during normal pregnancy and early life.
Protonotariou E; Rizos D; Malamitsi-Puchner A; Sarandakou A; Botsis D
In Vivo; 2006; 20(6B):901-5. PubMed ID: 17203787
[TBL] [Abstract][Full Text] [Related]
8. Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates.
Spong CY; Sherer DM; Ghidini A; Jenkins CB; Seydel FD; Eglinton GS
Obstet Gynecol; 1996 Jul; 88(1):24-8. PubMed ID: 8684756
[TBL] [Abstract][Full Text] [Related]
9. Measurement of CA 72.4 in maternal serum and amniotic fluid.
Tayyar M; Tutus A
J Perinat Med; 1998; 26(5):400-3. PubMed ID: 10027137
[TBL] [Abstract][Full Text] [Related]
10. Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies.
Steinberg G; Lee C; Rauh-Hain JA; Ecker J; Khankin EV; Hsu CD; Cohen B; Rana S; Karumanchi SA; Thadhani R; Hacker MR; Lim KH
Am J Obstet Gynecol; 2010 Mar; 202(3):299.e1-7. PubMed ID: 20207247
[TBL] [Abstract][Full Text] [Related]
11. Tissue polypeptide specific antigen (TPS) throughout normal pregnancy.
Kassanos D; Botsis D; Rizos D; Kontoravdis A; Sikiotis K; Phocas I; Sarandakou A; Creatsas G
Anticancer Res; 2000; 20(3B):2129-31. PubMed ID: 10928165
[TBL] [Abstract][Full Text] [Related]
12. Amniotic fluid--soluble vascular endothelial growth factor receptor-1 in preeclampsia.
Vuorela P; Helske S; Hornig C; Alitalo K; Weich H; Halmesmäki E
Obstet Gynecol; 2000 Mar; 95(3):353-7. PubMed ID: 10711543
[TBL] [Abstract][Full Text] [Related]
13. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester.
Yamada H; Furuta I; Kato EH; Kataoka S; Usuki Y; Kobashi G; Sata F; Kishi R; Fujimoto S
Reprod Toxicol; 2002; 16(6):735-9. PubMed ID: 12401500
[TBL] [Abstract][Full Text] [Related]
14. Soluble fas antigen and soluble fas ligand in intrauterine growth restriction.
Briana DD; Baka S; Boutsikou M; Liosi S; Vraila VM; Gourgiotis D; Hassiakos D; Malamitsi-Puchner A
Neonatology; 2010; 97(1):31-5. PubMed ID: 19590243
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of soluble Fas antigen and soluble Fas ligand in mother and newborn.
Iwama H; Akutsu H; Kuretake S; Tohma J; Nakamura N
Arch Gynecol Obstet; 2000 Feb; 263(3):108-10. PubMed ID: 10763837
[TBL] [Abstract][Full Text] [Related]
16. IGF-I, IGF-II, IGF binding protein 1, and C-peptide in second trimester amniotic fluid are dependent on gestational age but do not predict weight at birth.
Verhaeghe J; Coopmans W; van Herck E; van Schoubroeck D; Deprest JA; Witters I
Pediatr Res; 1999 Jul; 46(1):101-8. PubMed ID: 10400142
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 3 in parturition, premature rupture of the membranes, and microbial invasion of the amniotic cavity.
Park KH; Chaiworapongsa T; Kim YM; Espinoza J; Yoshimatsu J; Edwin S; Gomez R; Yoon BH; Romero R
J Perinat Med; 2003; 31(1):12-22. PubMed ID: 12661139
[TBL] [Abstract][Full Text] [Related]
18. Soluble tumor necrosis factor receptors in maternal plasma and second-trimester amniotic fluid.
Kupferminc MJ; Peaceman AM; Aderka D; Wallach D; Peyser MR; Lessing JB; Socol ML
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):900-5. PubMed ID: 7573266
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor concentration in the early second-trimester amniotic fluid does not predict fetal growth at birth.
Ohnishi Y; Yamashiro C; Yanagihara T; Hata T
Hum Reprod; 1999 Oct; 14(10):2625-8. PubMed ID: 10527998
[TBL] [Abstract][Full Text] [Related]
20. Total hemoglobin concentration in amniotic fluid is increased in intraamniotic infection/inflammation.
Vaisbuch E; Romero R; Erez O; Kusanovic JP; Gotsch F; Than NG; Mazaki-Tovi S; Mittal P; Edwin S; Hassan SS
Am J Obstet Gynecol; 2008 Oct; 199(4):426.e1-7. PubMed ID: 18928995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
